MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 156 filers reported holding MOMENTA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $13,298,000 | +60.7% | 253,400 | +1.9% | 0.01% | +42.9% |
Q2 2020 | $8,274,000 | +38.3% | 248,700 | +13.0% | 0.01% | +16.7% |
Q1 2020 | $5,984,000 | +40.1% | 220,000 | +1.6% | 0.01% | +50.0% |
Q4 2019 | $4,272,000 | +87.4% | 216,500 | +23.1% | 0.00% | +100.0% |
Q3 2019 | $2,280,000 | +5.2% | 175,900 | +1.0% | 0.00% | 0.0% |
Q2 2019 | $2,168,000 | -10.2% | 174,100 | +4.8% | 0.00% | -33.3% |
Q1 2019 | $2,415,000 | +34.5% | 166,200 | +2.2% | 0.00% | +50.0% |
Q4 2018 | $1,795,000 | -46.9% | 162,600 | +26.4% | 0.00% | -50.0% |
Q3 2018 | $3,382,000 | +31.6% | 128,600 | +2.4% | 0.00% | +33.3% |
Q2 2018 | $2,569,000 | +12.7% | 125,600 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $2,280,000 | +32.6% | 125,600 | +1.9% | 0.00% | +50.0% |
Q4 2017 | $1,720,000 | -19.6% | 123,300 | +6.6% | 0.00% | 0.0% |
Q3 2017 | $2,140,000 | +9.5% | 115,700 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $1,955,000 | +33.0% | 115,700 | +5.1% | 0.00% | 0.0% |
Q1 2017 | $1,470,000 | -11.3% | 110,100 | 0.0% | 0.00% | -33.3% |
Q4 2016 | $1,657,000 | +28.7% | 110,100 | 0.0% | 0.00% | +50.0% |
Q3 2016 | $1,287,000 | +4.8% | 110,100 | -3.2% | 0.00% | 0.0% |
Q2 2016 | $1,228,000 | +23.4% | 113,700 | +2.1% | 0.00% | 0.0% |
Q1 2016 | $995,000 | -26.7% | 111,400 | +21.7% | 0.00% | -33.3% |
Q4 2015 | $1,358,000 | -7.2% | 91,500 | +2.6% | 0.00% | -25.0% |
Q3 2015 | $1,464,000 | -18.3% | 89,200 | +13.5% | 0.00% | -20.0% |
Q2 2015 | $1,793,000 | +105.1% | 78,600 | +36.7% | 0.01% | +150.0% |
Q1 2015 | $874,000 | +31.2% | 57,500 | +4.0% | 0.00% | 0.0% |
Q4 2014 | $666,000 | +6.2% | 55,300 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $627,000 | -6.1% | 55,300 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $668,000 | +3.7% | 55,300 | 0.0% | 0.00% | -33.3% |
Q1 2014 | $644,000 | -17.5% | 55,300 | +25.1% | 0.00% | 0.0% |
Q4 2013 | $781,000 | +22.8% | 44,200 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $636,000 | -4.5% | 44,200 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $666,000 | – | 44,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MONROE HALL ASSET MANAGEMENT LLC | 200,000 | $3,282,000 | 1.60% |
SECTOR GAMMA AS | 350,920 | $5,759,000 | 1.56% |
Opaleye Management Inc. | 160,000 | $2,626,000 | 1.29% |
Visium Asset Management, LP | 5,398,088 | $88,583,000 | 1.21% |
Palo Alto Investors LP | 1,455,176 | $23,879,000 | 1.15% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 4,597,915 | $75,452,000 | 0.84% |
Sivik Global Healthcare LLC | 90,000 | $1,477,000 | 0.72% |
Campbell & CO Investment Adviser LLC | 45,887 | $753,000 | 0.50% |
Apex Capital Management | 1,096,757 | $17,998,000 | 0.41% |
AlphaMark Advisors, LLC | 42,651 | $700,000 | 0.39% |